6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology

6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology Banner


Date & Location
Monday, October 8, 2018 7:00 AM - Wednesday, October 10, 2018 1:00 PM   Rockefeller Research Laboratories 430 E 67th St, New York, NY

Target Audience
Medical Oncology, Molecular Pathology, Neurosurgery, Orthopaedic Surgery, Pathology, Pediatric Oncology, Pediatric Surgery, Radiation Oncology, Radiology-Diagnostic, Radiology-Interventional, Research Fellow, Spine Surgery, Surgical Oncology, Surgical Pathology

Overview

The 6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology is designed to give a current review of musculoskeletal tumor pathology and principles of management to orthopaedic surgeons, radiologists, pathologists, pediatric oncologists, medical oncologists and radiation oncologists.

This course covers the most common and clinically relevant benign and malignant musculoskeletal tumors, primary and metastatic, from diagnosis to integrated treatment and outcome. Emphasis is placed on clinic-radiographic and pathologic correlations, natural history and biology, multidisciplinary management, standard treatment and novel approaches.

Course Topics:

  • Benign Non Surgical & Surgical Lesions - Aneurysmal Bone Cyst, Bone Cyst, Chondromyxoid Fibroma, Chondroblastoma, Chondromas, Desmoplastic fibroma, Eosinophilic granuloma, Fibrous dysplasia, Giant cell tumor, Histiocytic fibroma, Myositis ossificans, Osteoblastoma, Osteochondromas, Osteoid osteoma
  • Malignant Tumors - Adamantinoma, Chondrosarcomas, Chordoma, Ewing’s sarcoma, Lymphoma, Myeloma, Osteosarcomas, Secondary Malignancies, Spindle and Pleomorphic Sarcomas, Vascular Tumors, Bone Metastases
  • Soft Tissue Tumors - Lipoma and Other Benign Soft Tissue Tumors, Liposarcoma, Fibrosarcoma, Malignant Fibrous Histiocytoma, Synovial Sarcomal, Rare Entities
  • Various - Biological Prognostic and Therapeutic Markers, Bone Allografts in Skeletal Reconstruction, Chemotherapy Issues and Future Trends, Integrated Treatment of Soft Tissue Sarcomas, Reconstruction in Children, Staging and Biopsy and Margins, Surgical Principles of Benign Lesions, Surgical Treatment of Spine Tumors
  • Special Sessions - Basic Research, Molecular Biology in the Diagnosis of Bone and Soft Tissue Tumors, Imaging of Bone and Soft Tissue Tumors, Limb Salvage Surgery

This course is in collaboration with the Hospital for Special Surgery (New York) and the Galeazzi Institute (Milan, Italy).



Objectives
  1. Enhance diagnostic tools based on clinical-radiographic-pathologic correlation.
  2. Enhance knowledge of tumor biology and relationship with treatment principles.
  3. Understand principles of multidisciplinary management.
  4. Refine knowledge of surgical management, with emphasis on limb salvage.

Registration

 Registration Fees  Early*  General  
 Physicians (MDs, PhDs and DOs)  $600   $650 
 Residents, Fellows, Nurses and Other Healthcare Providers      $400   $450 
 Industry Professionals**  $1,100   $1,150 

*Early Registration - Apply promo code 18MUSCEB at registration (deadline: September 7, 2018)
**Industry Professionals - Registration is for educational purposes only. Marketing, sales, and promotion of products and services are prohibited at CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

After your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.



Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.